Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

NCT00774696 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: clarithromycin 500mg tablets

Sponsor

Ranbaxy Laboratories Limited